KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

Kidney Disease among the Compacts of Free Association Pacific Islander Community: A Hidden Crisis

Rhee CM, Palafox NA, Hayashida G. Kidney Disease among the Compacts of Free Association Pacific Islander Community: A Hidden Crisis. Clin J Am Soc Nephrol.[...]

Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation

Rhee CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV. Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation. Curr Opin[...]

Bridging structure and function: artificial intelligence-based modelling of kidney proteins

Wu S, Wang W, Zhou ZH, Scalzo F, Kurtz I. Bridging structure and function: artificial intelligence-based modelling of kidney proteins. Nat Rev Nephrol. 2026 Mar[...]